Volume 330, Issue 6 pp. 173-176
Full Paper
Full Access

Bioorganometallic Chemistry – Synthesis and Antitumor Activity of Cobalt Carbonyl Complexes

Manfred Jung

Manfred Jung

Institut für Pharmazeutische Chemie, Westfälische Wilhelms-Universität Münster, Hittorfstr. 58–62, 48149 Münster, Germany

Search for more papers by this author
David E. Kerr

David E. Kerr

Institut für Pharmazeutische Chemie, Westfälische Wilhelms-Universität Münster, Hittorfstr. 58–62, 48149 Münster, Germany

Search for more papers by this author
Peter D. Senter

Peter D. Senter

Bristol-Myers Squibb, Pharmaceutical Research Institute, 3000 First Avenue, Seattle WA 98121, USA

Search for more papers by this author
First published: 22 September 2006
Citations: 55

Dedicated to Prof. Dr. Manfred Haake on the occasion of his 60th birthday.

Abstract

The interaction of organometallic compounds with biological systems, generally called bioorganometallic chemistry, is receiving increasing interest. We present the first part of our studies concerning the biological activity of organometallic compounds. Several alkyne-cobalt carbonyl complexes inhibited the growth of human melanoma and lung carcinoma cell lines. They are more active than uncomplexed dicobalt octacarbonyl, cobalt chloride, or the free ligand. A significant difference in potency towards the lung carcinoma cell line was observed among the cobalt complexes, indicating that the complexed ligand may influence cytotoxic activity. These results suggest that further exploratory work with such cobalt-alkyne complexes is warranted.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.